Le Lézard
Classified in: Health
Subjects: EXE, RCL

Advisory - Unauthorized prescription drug "Selekta Pregnenolone" sold online by A.N. Tyler Distributing may pose serious health risks


OTTAWA, July 28, 2017 /CNW/ -

Issue
Health Canada is advising Canadians that "Selekta Pregnenolone," an unauthorized prescription product sold online at www.antyler.com, may pose serious health risks. Health Canada seized the product from the company, A.N. Tyler Distributing.

Selekta Pregnenolone was being  promoted for anti-aging, arthritis, depression, menopause, mental fatigue, premenstrual syndrome, prostate disorders, skin irritation, scleroderma stress, women's health and supporting the immune system.

Who is affected

Affected product

What consumers should do

Background
Pregnenolone is a prescription drug that should only be used under the supervision of a healthcare professional. Pregnenolone can cause higher than normal levels of female and male hormones in the body and could increase the risk of prostate, breast, ovarian and other hormone-sensitive cancers. Pregnenolone should not be used by women who are pregnant or breast-feeding, and should be avoided by individuals who suffer from epileptic seizures or who are taking anti-seizure medications.

What Health Canada is doing
Health Canada seized the product from the company, A.N. Tyler Distributing. The company has agreed to stop selling and to recall the unauthorized product. Health Canada will monitor the company's recall. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians as necessary.

Related Links

For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: